Allarity Therapeutics, Inc.
ALLR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860657
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Allarity Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Allarity Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Jensen Thomas | CEO | 596,734 | May 14, 2026 | 1 |
| Hoeiland Jesper | Director | 25,000 | May 11, 2026 | 1 |
| McLaughlin Gerald W. | Director | 70,000 | May 7, 2026 | 1 |
| Ervin Jeffrey S | CFO | 150,000 | Apr 30, 2026 | 1 |
| Graff Jeremy R. | See Remarks | 381,644 | Apr 30, 2026 | 2 |
| Vazzano Joseph Walter | Director | – | Jan 24, 2025 | 0 |
| Benjamin Laura | Director | – | Jan 24, 2025 | 0 |
| Epshinsky Alexander | CFO | 85,051 | Jan 24, 2025 | 0 |
| Knudsen Jens Erik | Former Chief Financial Officer | – | Jul 14, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.